Straits Times Index
3,220.98 +47.05 (+1.48%) S&P 500
4,000.02 -2.85 (-0.07%) Dow
32,534.42 -26.18 (-0.08%) Nasdaq
11,846.32 -13.79 (-0.12%) BTC-USD
28,391.32 +420.17 (+1.50%) CMC Crypto 200
618.42 +2.47 (+0.40%)
Vetoquinol SA (0O1O.L)
| Previous close | 80.70 |
| Open | 80.30 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 80.30 - 81.10 |
| 52-week range | 80.30 - 81.10 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 948.643M |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | 23.76 |
| EPS (TTM) | 3.41 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
In 2023 Vetoquinol Celebrates Its 90th Anniversary
LURE, France, March 06, 2023--Regulatory News: Vetoquinol (Paris:VETO), the trusted partnerFor over 90 years, the company has been a key player in animal health. Today, it is one of the world's top 10 veterinary pharmaceutical companies. Since its creation in 1933, Vetoquinol has worked alongside veterinarians, breeders, pet owners and experts, devoting its efforts to the well-being and improvement of animal health.Today, the company offers a wide range of solutions for pets and livestock and fo
- Business Wire
Vetoquinol: Annual Sales 2022
LURE, France, January 18, 2023--Regulatory News: Matthieu Frechin, CEO of Vetoquinol (Paris:VETO), said: "The Covid-19 effect has led to exceptional growth in animal health markets in 2020 and 2021. This long-term trend remains, despite a weaker market in 2022. Our strategy of focusing on targeted market segments will enable us to continue to deliver profitable growth driven by our Essentials products."
- Business Wire
Vetoquinol: 2023 Calendar of Financial Communication
LURE, France, January 10, 2023--Regulatory News: Vetoquinol (Paris:VETO) published its calendar of financial communication for 2023.
